YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Houda Hachad, Vice President of Clinical Operations…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia®, and Houda…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia®, and Houda…
Read More
Aranscia® solutions help oncologists comply with new FDA warning label requiring DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ -- Oncologists and pharmacy experts are reacting to last…
Read More
Polypharmacy, adverse drug events, the Beers Criteria, and pain management. “Personalized prescribing in long-term care: Why it matters more than ever,” by Joel Diamond, CMO of YouScript's Partner, AccessDx Laboratory, in McKnight’s…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Kristine Ashcraft, President and Founder of YouScript,…
Read More
Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is…
Read More
A recent warning from the American Academy of Pediatrics has many parents worrying if their child is an ultrarapid metabolizer of the popular drug codeine. The clinical report is calling…
Read More
National Health IT Week celebrates the power of Health Information Technology to improve the health and healthcare of patients across the nation. The advantages and disadvantages of technology such as…
Read More
We're back again with another round of PGx Articles. Pharmacogenomics is on the rise, and with the groundswell of support we’re seeing, it’s only a matter of time before we…
Read More
